tiprankstipranks
Trending News
More News >
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
US Market

Bioxcel Therapeutics (BTAI) Income Statement

Compare
1,909 Followers

Bioxcel Therapeutics Income Statement

Last quarter (Q3 2025), Bioxcel Therapeutics's total revenue was $98.00K, a decrease of -54.21% from the same quarter last year. In Q3, Bioxcel Therapeutics's net income was $-30.91M. See Bioxcel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.27M$ 1.38M$ 375.00K$ 0.00$ 0.00
Gross Profit
$ 123.00K$ 120.00K$ 355.00K$ -297.00K$ 0.00
Operating Expenses
$ 67.37M$ 171.90M$ 160.00M$ 105.60M$ 82.30M
Depreciation and Amortization
$ 309.00K$ 318.00K$ 327.00K$ 297.00K$ 188.00K
EBITDA
$ -44.16M$ -165.42M$ -157.22M$ -107.00M$ -82.11M
Operating Income
$ -67.25M$ -171.78M$ -159.65M$ -105.89M$ -82.30M
Other Income/Expenses
$ 7.65M$ -7.27M$ -6.11M$ -1.40M$ 128.00K
Pretax Income
$ -59.60M$ -179.05M$ -165.76M$ -107.29M$ -82.17M
Net Income
$ -59.60M$ -179.05M$ -165.76M$ -106.93M$ -82.17M
Per Share Metrics
Basic EPS
$ -23.51$ -98.35$ -94.67$ -64.87$ -60.63
Diluted EPS
$ -23.51$ -98.35$ -94.67$ -64.87$ -60.63
Weighted Average Shares Outstanding
2.54M 1.82M 1.75M 1.65M 1.36M
Weighted Average Shares Outstanding (Diluted)
2.54M 1.82M 1.75M 1.65M 1.36M
Currency in USD

Bioxcel Therapeutics Earnings and Revenue History